Guidelines for regional genetic centres on the implementation of genetic services for the breast, ovarian and colorectal cancer families in Scotland

CME Journal of Gynecologic Oncology

Volumn 5, Issue 3, 2000, Pages 291-307

  Haites, N E ^a   Black, R ^a   Campbell, H ^a   Clark, C ^a   Davidson, R ^a   Davis, J ^a   Dunlop, M ^a   Goudie, D ^a   Irvine, L ^a   Porteous, M ^a   Smyth, J ^a   Steel, C M ^a   Stevenson, J M ^a   Thompson, A ^a   Wallace, E ^a   Whyte, F ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TAMOXIFEN;

BREAST CANCER; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; COUNSELING; FAMILY HISTORY; GENE; GENE MUTATION; HEALTH CARE; HETEROZYGOTE; HUMAN; HYSTERECTOMY; MAMMOGRAPHY; OVARIECTOMY; OVARY CANCER; PATIENT REFERRAL; PEDIGREE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; RESEARCH; REVIEW; TRANSVAGINAL ECHOGRAPHY; UNITED KINGDOM;

EID: 0034521834     PISSN: 12199087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Testing for the breast cancer predisposition gene, BRCA1
2. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
3. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer
4. The genetics of familial breast cancer and their practical implications
5. Effect of age, breast density, and family history on the sensitivity of first screening mammography
6. Familial breast cancer
7. Contribution of BRCA1 mutations to ovarian cancer
8. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence
9. Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic
10. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): An updated review
11. How accurate is self-reported family history of colorectal cancer?
12. Current surgical practice in screening for colorectal cancer based on family history criteria
13. Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls
14. Lessons from hereditary colorectal cancer
15. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients
16. Molecular basis of HNPCC: Mutations of MMR genes
17. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer
18. Genetic instability occurs in the majority of young patients with colorectal cancer
19. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease
20. Cancer risk associated with germline DNA mismatch repair gene mutations
21. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis
22. Recommendations for follow-up care of individuals with an inherited predisposition to cancer: I. Hereditary non-polyposis colon cancer
23. Update on the differential diagnosis, surveillance and management of hereditary non-polyposis colorectal cancer
24. Prevention of colorectal cancer by colonoscopic polypectomy
25. Evolution of hereditary non-polyposis colorectal cancer
26. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome)
27. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer
28. Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients: A controlled, prospective study
29. Hereditary nonpolyposis colorectal cancer: Results of long-term surveillance in 50 families
30. Endoscopic and surgical complications of work-up in screening for colorectal cancer
31. Colonoscopy: A prospective report of complications
32. Complications of diagnostic and therapeutic colonoscopy. Results of 10,000 examinations
33. A cost-effectiveness analysis of colorectal screening of hereditary non-polyposis colorectal carcinoma gene carriers